Cargando…

Quantitative assessment of background parenchymal enhancement in breast magnetic resonance images predicts the risk of breast cancer

The objective of this study was to evaluate the association betweenthe quantitative assessment of background parenchymal enhancement rate (BPER) and breast cancer. From 14,033 consecutive patients who underwent breast MRI in our center, we randomly selected 101 normal controls. Then, we selected 101...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xiaoxin, Jiang, Luan, Li, Qiang, Gu, Yajia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354686/ https://www.ncbi.nlm.nih.gov/pubmed/27895314 http://dx.doi.org/10.18632/oncotarget.13538

Ejemplares similares

Fibroglandular Tissue and Background Parenchymal Enhancement on Breast MR Imaging Correlates With Breast Cancer
por: Hu, Xiaoxin, et al.
Publicado: (2021)

Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients
por: You, Chao, et al.
Publicado: (2017)

Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging
por: Ko, Kyung Hee, et al.
Publicado: (2017)

Breast cancer and background parenchymal enhancement at breast magnetic resonance imaging: a meta-analysis
por: Hu, Na, et al.
Publicado: (2021)

Quantitative evaluation of Kaiser score in diagnosing breast dynamic contrast-enhanced magnetic resonance imaging for patients with high-grade background parenchymal enhancement
por: Wang, Hui, et al.
Publicado: (2023)

Correlation Between Mammographic Breast Density, Breast Tissue Type in Ultrasonography, Fibroglandular Tissue, and Background Parenchymal Enhancement in Magnetic Resonance Imaging
por: Alikhassi, Afsaneh, et al.
Publicado: (2018)

Background parenchymal enhancement in preoperative breast MRI
por: Kohara, Satoko, et al.
Publicado: (2015)

MRI Texture Analysis of Background Parenchymal Enhancement of the Breast
por: Amano, Yasuo, et al.
Publicado: (2017)

MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer
por: Moliere, Sebastien, et al.
Publicado: (2019)

Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging: Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
por: Choi, Ji Soo, et al.
Publicado: (2016)

Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study
por: Hruska, Carrie B., et al.
Publicado: (2018)

Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status
por: Goodburn, Rosie, et al.
Publicado: (2023)

Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

The Assessment of Background Parenchymal Enhancement (BPE) in a High-Risk Population: What Causes BPE?
por: You, Chao, et al.
Publicado: (2018)

Correction: Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status
por: Goodburn, Rosie, et al.
Publicado: (2023)

Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging
por: Kawamura, Akiko, et al.
Publicado: (2015)

MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women
por: Brooks, Jennifer D., et al.
Publicado: (2018)

The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI
por: Hellgren, Roxanna, et al.
Publicado: (2020)

Harmonization of Quantitative Parenchymal Enhancement in T(1)‐Weighted Breast MRI
por: van der Velden, Bas H.M., et al.
Publicado: (2020)

Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study
por: Watt, Gordon P., et al.
Publicado: (2020)

Post-Processing Bias Field Inhomogeneity Correction for Assessing Background Parenchymal Enhancement on Breast MRI as a Quantitative Marker of Treatment Response
por: Nguyen, Alex Anh-Tu, et al.
Publicado: (2022)

Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement
por: Kim, Soo-Yeon, et al.
Publicado: (2020)

The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers
por: Vreemann, Suzan, et al.
Publicado: (2018)

Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation With Breast Cancer Oncotype Dx Score
por: Zhang, Michelle, et al.
Publicado: (2021)

Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis()
por: Ben-David, Merav A., et al.
Publicado: (2019)

Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy()
por: Chen, Jeon Hor, et al.
Publicado: (2015)

Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study
por: Hruska, Carrie B., et al.
Publicado: (2016)

The value of imaging combined with clinicopathological features in the diagnosis of high-risk breast lesions
por: Zhou, Jiayin, et al.
Publicado: (2022)

Fully automatic classification of breast MRI background parenchymal enhancement using a transfer learning approach
por: Borkowski, Karol, et al.
Publicado: (2020)

Generalizable attention U-Net for segmentation of fibroglandular tissue and background parenchymal enhancement in breast DCE-MRI
por: Nowakowska, Sylwia, et al.
Publicado: (2023)

Radiomics of Tumor Heterogeneity in Longitudinal Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Fan, Ming, et al.
Publicado: (2021)

The Role of Diffusion-Weighted Imaging Based on Maximum-Intensity Projection in Young Patients with Marked Background Parenchymal Enhancement on Contrast-Enhanced Breast MRI
por: Park, Ga-Eun, et al.
Publicado: (2023)

Breast Magnetic Resonance Imaging and Its Impact on the Surgical Treatment of Breast Cancer
por: Tsina, Georgia, et al.
Publicado: (2014)

Association between MRI background parenchymal enhancement and lymphovascular invasion and estrogen receptor status in invasive breast cancer
por: Li, Jun, et al.
Publicado: (2019)

Background parenchymal enhancement: behavior during neoadjuvant chemotherapy for breast cancer and relationship with a pathological complete response
por: Teixeira, Sandra Regina Campos, et al.
Publicado: (2020)

Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI
por: La Forgia, Daniele, et al.
Publicado: (2021)

Challenges of non-mass enhancement breast lesions mimicking malignancy encountered on breast magnetic resonance imaging
por: Choi, Eun Jung
Publicado: (2023)

Multimodality Imaging of Breast Parenchymal Density and Correlation with Risk Assessment
por: Wengert, Georg J., et al.
Publicado: (2019)

Background Parenchymal Enhancement on Contrast-Enhanced Spectral Mammography: Influence of Age, Breast Density, Menstruation Status, and Menstrual Cycle Timing
por: Zhao, Shuang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1vq5ut855s4pmqt8hfoqip3cje